The 50th annual meeting of the American Society of Hematology (ASH) is set to kickoff this Saturday, December 6, in San Francisco.
Each year, the ASH annual meeting is a showcase for critical research and issues related to multiple myeloma and other hematological conditions. Results of important clinical trials are regularly announced at the meeting, as well as other valuable information on treatments under development.
This year’s four-day event is expected to attract more than 21,000 attendees. The meeting agenda includes more than 500 oral …
Read the full story »
The overall incidence and death rates from cancer fell for the first time in the United States for men and women. Death rates due to multiple myeloma decreased for both men and women. However, the risk of developing myeloma remained the same in women and increased in men.
The incidence rate is a measure of the risk of developing a specific disease, and the death or mortality rate is the number of deaths in a population. Incidence …
Read the full story »